Journal Home > Volume 7 , Issue 4

The purpose of this study was to investigate the possible prophylactic effects of Alpinia officinarum hance on experimentally induced acute and chronic colitis models, in-vivo and in-vitro. Acute and chronic colitis were induced in Male Wistar rats by administration of Dextran Sulfate Sodium (DSS) in drinking water. DSS induction exhibited colon shrinkage, increased the Disease Activity Index (DAI) score, increased the levels of inflammatory markers and caused severe anemia. DSS induced animals, co-treated with the hexane extract of Alpinia officinarum (HEAO) (200 mg/kg body wt), effectively suppressed colonic injury that was evidenced by the reduced DAI score, colon weight/length ratio, histological damage, proinflammatory markers and MPO activity. Further, it restored the colonic antioxidants near to normal levels by regulating the oxidative stress via attenuation of lipid peroxidation. Our results revealed that the degree of colitis caused by the administration of DSS was significantly attenuated by HEAO. In addition, the in-vitro study showed that HEAO treatment inhibited the proliferation of HT-29 cells and down regulated the mRNA expression of NF-κB and COX-2. Taken together, these results suggest that HEAO is a promising anti-oxidant and anti-inflammatory agent that support its possible therapeutic role in the treatment of colitis.


menu
Abstract
Full text
Outline
About this article

Anti-inflammatory activity of Alpinia officinarum hance on rat colon inflammation and tissue damage in DSS induced acute and chronic colitis models

Show Author's information Vijayabharathi RajendiranVidhya NatarajanSivasithamparam Niranjali Devaraj( )
Department of Biochemistry, University of Madras, Maraimalai Campus (Guindy), Chennai, 600025, India

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

The purpose of this study was to investigate the possible prophylactic effects of Alpinia officinarum hance on experimentally induced acute and chronic colitis models, in-vivo and in-vitro. Acute and chronic colitis were induced in Male Wistar rats by administration of Dextran Sulfate Sodium (DSS) in drinking water. DSS induction exhibited colon shrinkage, increased the Disease Activity Index (DAI) score, increased the levels of inflammatory markers and caused severe anemia. DSS induced animals, co-treated with the hexane extract of Alpinia officinarum (HEAO) (200 mg/kg body wt), effectively suppressed colonic injury that was evidenced by the reduced DAI score, colon weight/length ratio, histological damage, proinflammatory markers and MPO activity. Further, it restored the colonic antioxidants near to normal levels by regulating the oxidative stress via attenuation of lipid peroxidation. Our results revealed that the degree of colitis caused by the administration of DSS was significantly attenuated by HEAO. In addition, the in-vitro study showed that HEAO treatment inhibited the proliferation of HT-29 cells and down regulated the mRNA expression of NF-κB and COX-2. Taken together, these results suggest that HEAO is a promising anti-oxidant and anti-inflammatory agent that support its possible therapeutic role in the treatment of colitis.

Keywords: Inflammation, Antioxidants, Alpinia officinarum, Dextran sulfate sodium (DSS), Inflammatory bowel diseases (IBD)

References(42)

[1]

M.S. Geier, R.N. Butler, G.S. Howarth, Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics, Int. J. Food Microbiol. 115 (2007) 1–11.

[2]

D.K. Podolsky, Inflammatory bowel disease, N. Engl. J. Med. 347 (2002) 417–429.

[3]

Phil-Sun Oh and Kye-Taek Lim, Plant originated glycoprotein has anti-oxidative and anti-inflammatory eff; ;ects on dextran sulfate sodium-induced colitis in mouse, J. Biomed. Sci. 13 (549–560) (2006) 549.

[4]

I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, R. Nakaya, A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology 98 (3) (1990) 694–702.

[5]

L.G. Axelsson, E. Landstrom, T.J. Goldschmidt, A. Gronberg, A.C. Bylund-Fellenius, Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice, Inflamm. Res. 45 (1996) 181–191.

[6]

Tae Woon Kim, Jae Nam Seo, Young Ho Suh, Hyo Jin Park, Ju Hyun Kim, Ji Young Kim, Oh Kwon Ik, Involvement of lymphocytes in dextran sulfate sodium-induced experimental colitis, World J. Gastroenterol. 12 (2) (2006) 302–305.

[7]

Tzou-Chi Huang, Shinn-Shyong Tsai, Li-Fang Liu, Yu Lin Liu, Hung-Jen Liu, Kuo Pin Chuang, Effect of Arctium lappa L. in the dextran sulfate sodium colitis mouse model, World J. Gastroenterol. 16 (33) (2010) 4193–4199.

[8]

S.B. Hanauer, Inflammatory bowel disease, N. Engl. J. Med. 334 (1996) 841e8.

[9]

M. John, Pezzuto, Plant-derived anticancer agents, Biochem. Pharmacol. 53 (2) (1997) 121–133.

[10]

S. Ghosh, L. Rangan, Alpinia: the gold mine of future therapeutics, Biotechnology 3 (2013) 173.

[11]

Ning An, Hong-wu Zhang, Li-zhen Xu, Shi-lin Yang, Zhong-mei Zou, New diarylheptanoids from the rhizome of Alpinia officinarum Hance, Food Chem. 119 (2010) 513–517.

[12]

Griangsak Eumkeb, Santi Sakdarat, Supatcharee Siriwong, Reversing β-lactam antibiotic resistance of Staphylococcus aureus with galangin from Alpinia officinarum Hance and synergism with ceftazidime, Phytomedicine 18 (2010) 40–45.

[13]

Kacey Reid, Vincent Wright, Samson Omoregie, Anticancer Properties of Alpinia officinarum (Lesser Galangal) – a mini review, Int. J. Adv. Res. 4 (2016) 300–306.

[14]

Sabine Mercier, Denis Breuille, Laurent Mosoni, Christiane Obled, Philippe Patureau Mirand, Chronic inflammation alters protein metabolism in several organs of adult rats, Nutr. Metab. J. Nutr. 132 (2002) 1921–1928.

[15]

H.S. Cooper, S.N. Murthy, R.S. Shah, D.J. Sedergran, Clinicopathologic study of dextran sulfate sodium experimental murine colitis, Lab. Invest. 69 (1993) 238–249.

[16]
B.A. Brown, Textbook of Hematology Principle Procedures, 2nd edition, Lea and Febiger, Philadelphia. USA, 1976, pp. 56–81.
[17]
S.G. Hewitt, Manual for veterinary investigation, hematology and laboratory techniques, in: Bulleting of Ministry of Agric. Fishery, Food and Hematology, 3rd edition, 1984, pp. 77–79.
[18]
O.W. Schalm, N.C. Jain, E.J. Caroll, Textbook of Veterinary Hematology, 3rd edition, 1975.
[19]
J. King, The hydrolases-acid and alkaline phosphatases in: Practical Clinical Enzymology, D Van Nostrand Co., London, 1965, 199e208.
[20]
J. King, Lactate dehydrogenase, in: Practical Clinical Enzymology, D. Van Nostrand Co., London, 1965, pp. 3e93.
[21]

S.B. Rosali, D. Rau, Serum gamma-glutamyl transpeptidase activity in alcoholism, Clin. Chim. Acta 39 (1972) 41–47.

[22]
H.U. Bergmeyer, E. Bernt, Aminotransferases and related enzymes, in: H.U. Bergmeyer (Ed. ), Methods of Enzymatic Analysis, 2nd ed., Academic Press, New York, 1974, pp. 735–763.
DOI
[23]

P.P. Bradley, D.A. Priebat, R.D. Christensen, G. Rothstein, Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker, J. Invest. Dermatol. 78 (1982) 206–209.

[24]

J. Sedlak, R.H. Lindsay, Estimation of total protein bound and nonprotein sulfhydryl groups in tissues with Ellman's reagent, Anal. Biochem. 25 (1968) 192–205.

[25]

M.S. Moron, J.W. Depierre, B. Mannervik, Levels of glutathione, glutathione reductase and glutathione- S-transferase activities in rat lung and liver, Chin. J. Biochem. Biophys. 582 (1979) 67–78.

[26]

H.P. Misra, I. Fridovich, The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase, J. Biol. Chem. 247 (1972) 3170–3175.

[27]

S. Takahara, H.B. Hamilton, J.V. Neel, T.Y. Kobara, Y. Ogura, E.T. Nishimura, Hypocatalasemia: a new genetic carrier state, J. Clin. Invest. 39 (1960) 610–619.

[28]

J. Rotruck, A.L. T Pope, H.E. Ganther, A.B. Swanson, D.G. Hafeman, W.G. Hoekstra, Selenium: biochemical role as a component of glutathione peroxidise, Science 179 (1973) 588–590.

[29]

W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione S-transferases: the first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (22) (1974) 7130–7139.

[30]

H. Ohkawa, N. Ohishi, K. Yagi, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, Anal. Biochem. 95 (1979) 351–358.

[31]

C.O. Beauchamp, I. Fridovich, Superoxide dismutase: improved assays and an assay applicable to acrylamide gels, Anal. Biochem. 44 (1) (1971) 276–287.

[32]

Y. Sun, Free radicals, antioxidant enzymes, and carcinogenesis, Free Rad. Biol. Med. 8 (1990) 583–599.

[33]

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1–2) (1983) 55–63.

[34]

S. Ashorn, T. Honkanen, K.L. Kolho, M. Ashorn, T. Valineva, B. Wei, J. Braun, I. Rantala, T. Luukkaala, S. Iltanen, Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease, Inflamm. Bowel Dis. 15 (2) (2009) 199–205.

[35]

V. Uko, S. Thangada, K. Radhakrishnan, Liver disorders in inflammatory bowel disease, Gastroenterol. Res. Pract. (2012) 642923.

[36]

S. Wirtz, M.F. Neurath, Mouse models of inflammatory bowel disease, Adv. Drug Delivery Rev. 59 (2007) 1073–1083.

[37]

L. Camacho-Barquero, I. Villegas, J.M. Sanchez-Calvo, E. Talero, S. Sanchez-Fidalgo, V. Motilva, C. Alarcon de la Lastra, Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis, Int. Immunopharmacol. 7 (2007) 333–342.

[38]

E. Talero, S. Sanchez-Fidalgo, J. Ramon Calvo, V. Motilva, Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis, Int. Immunopharmacol. 1 (6) (2006) 1404–1412.

[39]

A.K. Pandurangan, Z. Saadatdoust, H. Hamzah, A. Ismail, Dietary cocoa protects against colitis associated cancer by activating the Nrf2/Keap1 pathway, BioFactors 41 (2015) 14.

[40]

A. DOdorico, S. Bortolan, R. Cardin, R. DInca, D. Martines, A. Ferronato, G.C. Sturniolo, Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease, Scand. J. Gastroenterol. 12 (2001) 1289–1294.

[41]

I. Masoodi, R. Kochhar, U. Dutta, C. Vaishnavi, K.K. Prasad, K. Vaiphei, S. Kaur, K. Singh, Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis, J. Gastroenterol. Hepatol. 24 (11) (2009) 1768–1774.

[42]

J.C. Hardwick, G.R. van den Brink, G.J. Offerhaus, S.J. van Deventer, M.P. Peppelenbosch, NF-κB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps, Oncogene 20 (2001) 819–827.

Publication history
Copyright
Rights and permissions

Publication history

Received: 09 July 2018
Revised: 28 October 2018
Accepted: 31 October 2018
Published: 03 November 2018
Issue date: December 2018

Copyright

© 2018 “Society information”.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return